Beclomethasone Dipropionate Patent Expiration

Beclomethasone Dipropionate was first introduced by Schering Corp Sub Schering Plough Corp in its drug Vanceril on Approved Prior to Jan 1, 1982. Other drugs containing Beclomethasone Dipropionate are Qnasl, Vanceril Double Strength, Vancenase, Qvar 40, Qvar 80, Beconase, Beclovent, Qvar Redihaler. 4 different companies have introduced drugs containing Beclomethasone Dipropionate.


Beclomethasone Dipropionate Patents

Given below is the list of patents protecting Beclomethasone Dipropionate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Qnasl US10188811 Nasal spray device Oct 21, 2031 Teva Branded Pharm
Qnasl US5605674 Medicinal aerosol formulations Feb 25, 2014

(Expired)

Teva Branded Pharm
Qnasl US5683677 Medicinal aerosol formulations Nov 04, 2014

(Expired)

Teva Branded Pharm
Qnasl US5776432 Beclomethasone solution aerosol formulations Jul 07, 2015

(Expired)

Teva Branded Pharm
Qnasl US7780038 Dispensing apparatus with dosage counter Jan 24, 2027 Teva Branded Pharm
Qvar 40 US10022509 Dose counter for inhaler having a bore and shaft arrangement May 18, 2031 Teva Branded Pharm
Qvar 40 US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Branded Pharm
Qvar 40 US10086156 Dose counter for inhaler and method for counting doses May 18, 2031 Teva Branded Pharm
Qvar 40 US10561808 Dose counter for inhaler having an anti-reverse rotation actuator Jan 01, 2032 Teva Branded Pharm
Qvar 40 US10695512 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar 40 US11395889 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar 40 US5605674 Medicinal aerosol formulations Feb 25, 2014

(Expired)

Teva Branded Pharm
Qvar 40 US5683677 Medicinal aerosol formulations Nov 04, 2014

(Expired)

Teva Branded Pharm
Qvar 40 US5776432 Beclomethasone solution aerosol formulations Jul 07, 2015

(Expired)

Teva Branded Pharm
Qvar 40 US6446627 Inhaler dose counter Dec 18, 2017

(Expired)

Teva Branded Pharm
Qvar 40 US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Branded Pharm
Qvar 40 US9808587 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar 80 US10022509 Dose counter for inhaler having a bore and shaft arrangement May 18, 2031 Teva Branded Pharm
Qvar 80 US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Branded Pharm
Qvar 80 US10086156 Dose counter for inhaler and method for counting doses May 18, 2031 Teva Branded Pharm
Qvar 80 US10561808 Dose counter for inhaler having an anti-reverse rotation actuator Jan 01, 2032 Teva Branded Pharm
Qvar 80 US10695512 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar 80 US11395889 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar 80 US5605674 Medicinal aerosol formulations Feb 25, 2014

(Expired)

Teva Branded Pharm
Qvar 80 US5683677 Medicinal aerosol formulations Nov 04, 2014

(Expired)

Teva Branded Pharm
Qvar 80 US5776432 Beclomethasone solution aerosol formulations Jul 07, 2015

(Expired)

Teva Branded Pharm
Qvar 80 US6446627 Inhaler dose counter Dec 18, 2017

(Expired)

Teva Branded Pharm
Qvar 80 US9463289 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Teva Branded Pharm
Qvar 80 US9808587 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Teva Branded Pharm
Qvar Redihaler US10022509 Dose counter for inhaler having a bore and shaft arrangement May 18, 2031 Norton Waterford
Qvar Redihaler US10022510 Dose counters for inhalers, inhalers and methods of assembly thereof May 18, 2031 Norton Waterford
Qvar Redihaler US10086156 Dose counter for inhaler and method for counting doses May 18, 2031 Norton Waterford
Qvar Redihaler US10561808 Dose counter for inhaler having an anti-reverse rotation actuator Jan 01, 2032 Norton Waterford
Qvar Redihaler US10695512 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Norton Waterford
Qvar Redihaler US10792447 Breath actuated inhaler Jan 25, 2039 Norton Waterford
Qvar Redihaler US11395888 Inhalers and related methods Jan 26, 2038 Norton Waterford
Qvar Redihaler US11395889 Dose counter for inhaler having an anti-reverse rotation actuator May 18, 2031 Norton Waterford
Qvar Redihaler US11559637 Inhalers and related methods Jul 21, 2039 Norton Waterford
Qvar Redihaler US11583643 Inhalers and related methods Aug 19, 2041 Norton Waterford
Qvar Redihaler US11793953 Inhalers and related methods Jan 26, 2038 Norton Waterford
Qvar Redihaler US11865247 Inhalers and related methods Jan 26, 2038 Norton Waterford
Qvar Redihaler US11896759 Inhalers and related methods Jan 26, 2038 Norton Waterford
Qvar Redihaler US11957832 Breath actuated inhaler May 05, 2041 Norton Waterford
Qvar Redihaler US6446627 Inhaler dose counter Dec 18, 2017

(Expired)

Norton Waterford
Qvar Redihaler US7637260 Medicament dispensing device with a multimaterial diaphragm bounding a pneumatic force chamber Aug 25, 2020

(Expired)

Norton Waterford
Qvar Redihaler US8132712 Metered-dose inhaler Sep 07, 2028 Norton Waterford
Qvar Redihaler US8931476 Inhaler Jul 17, 2031 Norton Waterford


A patent's expiry date may change depending upon legal activities going on that patent. Critical activities like abandoning of a patent, term extension of a patent or amendment of its claims can increase or decrease the life of a patent hence affecting its expiry date and in turn affecting the generic launch date of that drug. Tracking these ongoing activities on a patent application helps to keep an eye on the latest developments in the patent process of the drug which can give an idea of how early a drug's generic could be available. The next section provides a list of recent legal activities on Beclomethasone Dipropionate's patents.

Given below is the list recent legal activities going on the following patents of Beclomethasone Dipropionate.

Event Date Patent/Publication
Patent litigations
Payment of Maintenance Fee, 4th Year, Large Entity 21 Mar, 2024 US10792447
Recordation of Patent Grant Mailed 13 Feb, 2024 US11896759
Recordation of Patent eGrant 13 Feb, 2024 US11896759
Email Notification 13 Feb, 2024 US11896759
Patent Issue Date Used in PTA Calculation 13 Feb, 2024 US11896759
Patent eGrant Notification 13 Feb, 2024 US11896759
Mail Patent eGrant Notification 13 Feb, 2024 US11896759
Email Notification 25 Jan, 2024 US11896759
Issue Notification Mailed 24 Jan, 2024 US11896759
Dispatch to FDC 16 Jan, 2024 US11896759



Coming Soon

Patent Strength Analyzer

Will this be useful for you?

YesNo

Thank you for your response 🥳